Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
Kallmeyer A, Pello A, Cánovas E, Aceña Á, González-Casaus ML, Tarín N, Cristóbal C, Gutiérrez-Landaluce C, Huelmos A, Rodríguez-Valer A, González-Lorenzo Ó, Alonso J, López-Bescós L, Egido J, Mahillo I, Lorenzo Ó, Tuñón J.
Kallmeyer A, et al. Among authors: egido j.
ESC Heart Fail. 2024 Feb;11(1):240-250. doi: 10.1002/ehf2.14568. Epub 2023 Nov 10.
ESC Heart Fail. 2024.
PMID: 37950429
Free PMC article.